Search results
Results from the WOW.Com Content Network
Acute rejection is a category of rejection that occurs on the timescale of weeks to months, with most episodes occurring within the first 3 months to 1 year after transplantation. [ 6 ] [ 8 ] Unlike hyperacute rejection, acute rejection is thought to arise from two distinct immunological mechanisms as lymphocytes , a subset of white blood cells ...
[2] [19] Adults are significantly likely to suffer from hyperacute rejection, [1] thrombosis, or death, but could be considered to be an acceptable risk if the alternative is death. [6] In the case of ABOi renal transplantation, aggressive antibody removal is required, along with supplemental medication, with the resulting condition being ...
Recipient's blood already contains circulating antibodies before the transplantation [3] – either IgM or antibodies incurred by previous immunization (e.g. by repeated blood transfusion). In case of hyperacute rejection, antibodies activate complement; moreover, the reaction can be enhanced by neutrophils. This type of rejection is very fast ...
A novel approach to organ transplantation allowed patients to wean off anti-rejection drugs after two years, according to the results of a phase 3 clinical trial presented Monday.
Rejection of the xenograft in hyperacute and acute vascular rejection is due to the response of the humoral immune system, since the response is elicited by the XNAs. Cellular rejection is based on cellular immunity , and is mediated by natural killer cells that accumulate in and damage the xenograft and T-lymphocytes which are activated by MHC ...
Cardiac allograft vasculopathy (CAV) is a progressive type of coronary artery disease in people who have had a heart transplant. [1] As the donor heart has lost its nerve supply there is typically no chest pain, and CAV is usually detected on routine testing. [2]
Autoimmune disease is a frequent complication after human allogeneic thymus transplantation, found in 42% of subjects over one year post-transplantation. [28] However, this is partially explained by the fact that the indication itself, that is, complete DiGeorge syndrome , increases the risk of autoimmune disease.
Transplant rejection (hyperacute, acute or chronic) [75] Infections and sepsis due to the immunosuppressant drugs that are required to decrease risk of rejection [76] (e.g., Tuberculosis, Cytomegalovirus colitis) [77] Post-transplant lymphoproliferative disorder (a form of lymphoma due to the immune suppressants).